Oppenheimer Maintains Outperform on Itron, Raises Price Target to $110
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Noah Kaye maintains an Outperform rating on Itron (NASDAQ:ITRI) and raises the price target from $100 to $110.
May 03, 2024 | 1:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer analyst Noah Kaye reaffirmed an Outperform rating on Itron and increased the price target to $110 from $100.
The increase in price target by a reputable analyst like Noah Kaye suggests a strong confidence in Itron's future performance. This endorsement is likely to positively influence investor sentiment and could lead to a short-term increase in ITRI's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100